A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas

Background: Meningiomas are the most common adult primary intracranial tumors in the United States. Despite high recurrence rate of atypical and malignant subtypes, there is no approved drug indicated specifically for meningioma. Since the majority of meningiomas exhibit high density of somatostatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hrachova, Maya, Nguyen, Emely Nhi T., Fu, Beverly D., Dandekar, Manisha J., Kong, Xiao-Tang, Cadena, Gilbert, Hsu, Frank P. K., Billimek, John, Taylor, Thomas H., Bota, Daniela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218113/
https://www.ncbi.nlm.nih.gov/pubmed/32435228
http://dx.doi.org/10.3389/fneur.2020.00373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218113/
https://www.ncbi.nlm.nih.gov/pubmed/32435228
http://dx.doi.org/10.3389/fneur.2020.00373

Ejemplares similares